Bypass graft material and myocardial protective procedure in combined coronary artery bypass grafting and valve surgery

2000 ◽  
Vol 48 (9) ◽  
pp. 574-578
Author(s):  
Hirofumi Fujii ◽  
Hajime Otani ◽  
Takanori Oka ◽  
Yutaka Hino ◽  
Hiroyoshi Fujiwara ◽  
...  
2014 ◽  
Vol 147 (6) ◽  
pp. 1925-1930 ◽  
Author(s):  
Matthew J. Hafermann ◽  
Tyree H. Kiser ◽  
Clark Lyda ◽  
Douglas N. Fish ◽  
Gerard R. Barber ◽  
...  

1999 ◽  
Vol 118 (5) ◽  
pp. 958-959
Author(s):  
Johanna J.M. Takkenberg ◽  
Timothy A. Denton ◽  
Rémon Baaka ◽  
Alfredo Trento ◽  
Ewout W. Steyerberg ◽  
...  

Cardiology ◽  
2015 ◽  
Vol 133 (3) ◽  
pp. 191-194
Author(s):  
Saum A. Rahimi ◽  
Noor Shah ◽  
Volodymyr Labinskyy ◽  
Leonard Y. Lee

Coronary subclavian steal syndrome is a rare but important condition that occurs after a left internal mammary artery (LIMA) to coronary artery bypass in the setting of a stenotic left subclavian artery. The lack of blood flow through the subclavian artery causes the reversal of flow in the LIMA so that it essentially steals blood from the myocardium. In order to avoid this complication, many surgeons now opt to either revascularize the stenotic subclavian artery prior to coronary artery bypass grafting or to use an alternate vessel as the bypass graft. Here, we present the case of an asymptomatic patient with poor exercise tolerance who was recently diagnosed with both triple-vessel coronary disease and peripheral arterial disease, which was most notably characterized by occlusion of the left subclavian artery. This case demonstrates the surgical management of this complex clinical entity.


Author(s):  
Gregory D. Trachiotis

Studies have demonstrated that antagonists of platelet activity, including aspirin and clopidogrel, reduce the risk of major adverse events in patients with acute coronary syndromes. Although antiplatelet agents also convey an increased risk of bleeding, particularly in patients proceeding to coronary artery bypass graft surgery, in most cases, the benefits of early initiation of antiplatelet therapy outweigh the risks. The purpose of this review is to distinguish perceived and actual risk versus the benefit associated with early antiplatelet therapy to help clinicians make informed decisions on using these agents in an acute setting where patients may require coronary artery bypass grafting.


Sign in / Sign up

Export Citation Format

Share Document